News & media IR firm focused on shaping and publishing 100s of great stories every year in the financial markets that inform current shareholders while attracting new retail and institutional investors.
Stock Market Media Group is a content rich investor relations firm offering CEO's the platform to tell their company's story in the media. We provide Feature News Articles, Corporate Videos, Research Reports, and CEO Interviews that help publicly traded companies inform current and potential new shareholders in the Market.
K9 Gold Corp.’s Stony Lake Project Ideally Positioned for Success in Central Newfoundland’s “Gold Belt”
NEW YORK, NY, Nov. 30, 2020 (GLOBE NEWSWIRE) -- K9 Gold Corp.’s (OTC Pink: WDFCF) (TSXV: KNC) (FSE: 5GP) Stony Lake Project is perfectly situated among...
K9 Gold Corp. Yielding High Quality Gold Samples at Stony Lake Project as CEO Discusses Company’s Promising Exploration
NEW YORK, NY, Nov. 16, 2020 (GLOBE NEWSWIRE) -- K9 Gold Corp. (OTC Pink: WDFCF) (TSXV: KNC) (FSE: 5GP) continues to ramp up exploration of its extremely...
SPYR Technologies Appoints Renowned International Technology, Media & Telecommunications Attorney John P. Formichella to Board of Directors
Mr. Formichella is a U.S. trained attorney and a leading expert in the Technology, Media& Telecommunications sector. Mr. Formichella has also served as an advisor to local chambers of commerce and US Embassies in Thailand and Taiwan, and governmental bodies regarding Technology, Media& Telecommunica...
SPYR Technologies Enters Apple HomeKit-Enabled Devices Market with Acquisition of IoT Technology Company
Denver, CO - (NewMediaWire) - October 21, 2020 - SPYR Technologies, Inc. (OTC Pink: SPYR), a holding company involved in building a portfolio of technology companies through targeted acquisitions, today announced that it has acquired Applied MagiX Inc., a registered Apple developer, and reseller of....
Proper Wild Converting Energy Drink Consumers with Clean, All-Day Plant-Based Energy Shot as Alternative to 5-hour ENERGY®
NEW YORK, NY, Oct. 19, 2020 (GLOBE NEWSWIRE) -- For any upstart company trying to find its way into a competitive industry, often the best way to...
SPYR Technologies Announces $15 Million Financing
Denver, CO - (NewMediaWire) - October 12, 2020 - SPYR Technologies (OTC Pink: SPYR), a holding company involved in building a portfolio of technology companies through targeted acquisitions, today announced that it has secured $15 million in funding commitments for acquisitions and corporate expansi...
SPYR, Inc. Begins Operating Under the Trade Name SPYR Technologies
--via NewMediaWire-- SPYR, Inc., a holding company involved in building a portfolio of technology companies through targeted acquisitions, today announced that it has filed a trade name in order to do business as SPYR Technologies effective immediately.. SPYR President and Chief Executive Officer, J...
World High Life Subsidiary Discusses Product Development, Brand Ambassador, Georges St-Pierre, and New Brands
NEW YORK, NY, Sept. 03, 2020 (GLOBE NEWSWIRE) -- World High Life (OTCQB: WRHLF) and its wholly owned subsidiary, Love Hemp, a London-based CBD company...
PharmaCyte Biotech Announces IND Submitted to U.S. FDA for Clinical Trial in Locally Advanced, Inoperable Pancreatic Cancer
PharmaCyte Biotech announces its IND submission to the FDA for its clinical trial in locally advanced, inoperable pancreatic cancer.
World High Life Subsidiary Expanding CBD Operations As Record Year-Long Sales Growth Continues
NEW YORK, NY, Aug. 27, 2020 (GLOBE NEWSWIRE) -- World High Life (OTCQB: WRHLF) acquired its wholly owned subsidiary, Love Hemp, less than a year ago, and...
Dow ends above 28,000 for first time in 6 months, S&P 500 and Nasdaq clinch new records on coronavirus treatment hopes
Major U.S. benchmarks close near their intraday peaks Monday, after the S&P 500 and Nasdaq Composite set records at the opening bell, as hopes for a...
Dow jumps 190 points, S&P 500 closes at another record to finish week
Stocks rose on Friday, lifted by strong U.S. economic data, to end a week that saw the broader market reach a record level.
$SPYR undergoing accumulation and the price is responding. Low float stock that has seen $1+ several times, so could it be heading there again?
Join 1000s who already get our content delivered directly to their inbox--be the first to know what's in play.
Stock Market Media Group Email Forms
PharmaCyte Biotech Ready to Submit Investigational New Drug Application to FDA for Clinical Trial in Pancreatic Cancer
NEW YORK, NY, Aug. 03, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has reached what can only be described as a momentous milestone in its...
Great News!! Should be the last piece of business before filing the IND.
>> PharmaCyte Biotech Announces Submission of Drug Master File to FDA for Company’s Pancreatic Cancer Therapy $PMCB #cancer #PancreaticCancer #FDA
PharmaCyte Biotech, Inc., a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ®, announced today that its partner, Austrianova, has submitted a Drug Master File to the U.S. Food and Drug Admin...
World High Life Capitalizing on Both Popular and New CBD Brands in Solid 2020 Campaign for Love Hemp
NEW YORK, NY, July 20, 2020 (GLOBE NEWSWIRE) -- Halfway through 2020 and World High Life (OTCQB: WRHLF) has seen considerable sales numbers lead to two...
Love Hemp Thriving in 2020 Leading the Way for World High Life in the CBD and Hemp Markets
NEW YORK, NY, June 29, 2020 (GLOBE NEWSWIRE) -- World High Life’s (OTCQB: WRHLF) wholly owned subsidiary, Love Hemp, is embracing the idea, “when life...
PharmaCyte Biotech’s COVID-19 Test Offers “Pool Testing” Dr. Fauci and White House Coronavirus Task Force Now Considering
NEW YORK, NY, June 29, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) may have what the White House Coronavirus Task Force is looking for just...
World High Life Subsidiary Continues Massive Sales Growth in the UK CBD Market with Eye to Future Brand Expansion
NEW YORK, NY, June 15, 2020 (GLOBE NEWSWIRE) -- World High Life Plc. (OTCQB: WRHLF) is building an investment portfolio in the legal medicinal cannabis,...
World High Life Realizing Strong Growth in the CBD and Hemp Industries with Acquisition of Love Hemp
NEW YORK, NY, June 01, 2020 (GLOBE NEWSWIRE) -- World High Life Plc. (OTCQB: WRHLF) has moved boldly into the legal medicinal cannabis, hemp and CBD...
Stock Market Media's cover photo
PharmaCyte Biotech Receives Medical Devices Registration and Submits Pre-EUA Application to the FDA for COVID-19 Diagnostic Kit https://www.businesswire.com/news/home/20200506005343/en/PharmaCyte-Biotech-Receives-Medical-Devices-Registration-Submits
PharmaCyte Biotech receives medical device registration and submits Pre-EUA application to the FDA for COVID-19 diagnostic kit.
PharmaCyte Biotech Completes Medical Manual for IND Filing - PharmaCyte Biotech
LAGUNA HILLS, CA May 4, 2020 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has completed a medic...
PharmaCyte Biotech Successfully Completes Pyrogenicity Testing
LAGUNA HILLS, CA, April 27, 2019 (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has successfully comp...
Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path to FDA EUA, and Commercialization
NEW YORK, NY, April 20, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) recently entered into a licensing agreement with Hai Kang Life...
PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic
NEW YORK, NY, March 26, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) continues to work with consultants to prepare its Investigational New...
PharmaCyte Biotech Receives Certificates of Analysis and Batch Records for its Clinical Trial Product in Pancreatic Cancer - PharmaCyte Biotech
LAGUNA HILLS, CA February 12, 2020 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has received th...
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins
NEW YORK, NY, Jan. 27, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) announced that its clinical trial product, which will be employed during...
PharmaCyte Biotech Successfully Completes All Release Tests on Clinical Trial Product
PharmaCyte Biotech, Inc. (otcqb:PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell...
GBT Technologies Transforming the Future Healthcare AI Market
NEW YORK, NY, Jan. 16, 2020 (GLOBE NEWSWIRE) -- GBT Technologies, Inc. (OTC PINK: GTCH) (GBT) is among a handful of companies that are developing...
PharmaCyte Biotech Addressing Unmet Need in Patients with LAPC as Pancreatic Cancer 5-Year Survival Rate Increases to 10%
NEW YORK, NY, Jan. 14, 2020 (GLOBE NEWSWIRE) -- This month the American Cancer Society announced that for the first time ever, the 5-year survival rate...
PharmaCyte Biotech Set to Reach Three Major Milestones in 2020
NEW YORK, NY, Jan. 06, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech’s (OTCQB: PMCB) shareholders should expect 2020 to be the year that ushers in a host...
PharmaCyte Biotech Finalizes Pancreatic Cancer Treatment for U.S. FDA Approval to Begin Clinical Trial
NEW YORK, NY, Dec. 11, 2019 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has a clinical trial product, a clinical trial protocol, including a...
Be the first to know and let us send you an email when Stock Market Media posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Stock Market Media:
Stock Market Media Group is a content development investor relations firm engaged in shaping, telling and publishing corporate stories in an effort to help companies grow their footprint, gain exposure and build their investor base. At the same time, our goal is to inform investors and attract both retail and institutional investors to newer and smaller companies in the publicly traded markets. We provide companies with a number of avenues to connect with the market--whether it be through feature news articles, corporate videos, research reports, press releases, or CEO interviews--we’re delivering content that helps publicly traded companies inform current and potential new shareholders in the market about their story and their company.